|
L3MBTL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.755700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.737800E-02 |
| Normal-vs-Stage2 |
2.704400E-01 |
| Normal-vs-Stage3 |
7.673200E-01 |
| Normal-vs-Stage4 |
3.952200E-01 |
| Stage1-vs-Stage2 |
6.864800E-01 |
| Stage1-vs-Stage3 |
4.882800E-01 |
| Stage1-vs-Stage4 |
1.959190E-01 |
| Stage2-vs-Stage3 |
4.478200E-01 |
| Stage2-vs-Stage4 |
2.069200E-01 |
| Stage3-vs-Stage4 |
4.513400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.537400E-03 |
| Normal-vs-AfricanAmerican |
6.146400E-02 |
| Normal-vs-Asian |
1.198580E-01 |
| Caucasian-vs-AfricanAmerican |
9.319800E-01 |
| Caucasian-vs-Asian |
9.157700E-03 |
| AfricanAmerican-vs-Asian |
1.054290E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.506250E-02 |
| Normal-vs-Female |
1.591630E-02 |
| Male-vs-Female |
4.273600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.473600E-01 |
| Normal-vs-Extreme_Weight |
2.146400E-01 |
| Normal-vs-Obese |
2.114000E-02 |
| Normal-vs-Extreme_Obese |
8.016800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.937000E-01 |
| Normal_Weight-vs-Obese |
1.041430E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.877200E-01 |
| Extreme_Weight-vs-Obese |
2.967000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.742400E-01 |
| Obese-vs-Extreme_Obese |
2.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.212400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.624600E-04 |
| Normal-vs-Age(61-80Yrs) |
6.072200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.215400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.826600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.237800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.639400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.517170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.054100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.703750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.20280000004414E-06 |
| Normal-VS-Type2 PRCC |
1.806640E-01 |
| Normal-VS-KIRP CIMP |
5.014800E-01 |
| Normal-VS-Unclassified PRCC |
3.279400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.20720000054797E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.954200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.035420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.756200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.955900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.967960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.358200E-01 |
| Normal-vs-N1 |
1.840390E-01 |
| Normal-vs-N2 |
1.258640E-01 |
| N0-vs-N1 |
7.082500E-02 |
| N0-vs-N2 |
5.910600E-01 |
| N1-vs-N2 |
2.291800E-01 |
|
|
